Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms (Q38642318)

5 September 2017

Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

5 September 2017

1 reference

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592314%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

I Rodriguez-Ramiro

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592314%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

A M Minihane

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592314%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

23 November 2015

1 reference

Proceedings of the Nutrition Society

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592314%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

1-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592314%20AND%20SRC:MED&resulttype=core&format=json

Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Moro orange juice prevents fatty liver in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Free radical biology for medicine: learning from nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: possible implication of the sirtuin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Modulation of metabolic syndrome-related inflammation by cocoa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

A polyphenol extract of Hibiscus sabdariffa L. ameliorates acetaminophen-induced hepatic steatosis by attenuating the mitochondrial dysfunction in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Resveratrol commonly displays hormesis: occurrence and biomedical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Selective versus total insulin resistance: a pathogenic paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Cyanidin-3-O-β-glucoside protects primary mouse hepatocytes against high glucose-induced apoptosis by modulating mitochondrial dysfunction and the PI3K/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Procyanidin B2 induces Nrf2 translocation and glutathione S-transferase P1 expression via ERKs and p38-MAPK pathways and protect human colonic cells against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

AMP-activated protein kinase and its downstream transcriptional pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Fatty acid-regulated transcription factors in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKCζ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

A human hepatocellular in vitro model to investigate steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Flavonoids: antioxidants or signalling molecules?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Resveratrol inhibits nonalcoholic fatty liver disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

The burden of liver disease in Europe: a review of available epidemiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Fatty liver: role of inflammation and fatty acid nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Comparative effects of dietary flavanols on antioxidant defences and their response to oxidant-induced stress on Caco2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Dose translation from animal to human studies revisited

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Neonatal exposure to genistein ameliorates high-fat diet-induced non-alcoholic steatohepatitis in rats

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Modulation of lipid metabolism by polyphenol-rich grape skin extract improves liver steatosis and adiposity in high fat fed mice

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not w

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665115004218

7 January 2021

Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content

1 reference

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1093/DATABASE/BAT070

Identifiers

DOI

10.1017/S0029665115004218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26592314%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference